280 related articles for article (PubMed ID: 9218183)
1. Role of kinins and angiotensin II in the vasodilating action of angiotensin converting enzyme inhibition in rat renal vessels.
Endlich K; Steinhausen M
J Hypertens; 1997 Jun; 15(6):633-41. PubMed ID: 9218183
[TBL] [Abstract][Full Text] [Related]
2. Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats.
Benetos A; Levy BI; Lacolley P; Taillard F; Duriez M; Safar ME
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3196-201. PubMed ID: 9409311
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the formation or action of angiotensin II reverses attenuated K+ currents in type 1 and type 2 diabetes.
Shimoni Y
J Physiol; 2001 Nov; 537(Pt 1):83-92. PubMed ID: 11711563
[TBL] [Abstract][Full Text] [Related]
4. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
[TBL] [Abstract][Full Text] [Related]
5. Pressure overload per se rather than cardiac angiotensin converting enzyme activity may be important in the development of rat cardiac hypertrophy.
Mukawa H; Toki Y; Shimauchi A; Matsui H; Morishima I; Okumura K; Ito T; Hayakawa T
J Hypertens; 1997 Sep; 15(9):1027-32. PubMed ID: 9321751
[TBL] [Abstract][Full Text] [Related]
6. Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: role of kinins.
Komers R; Cooper ME
Am J Physiol; 1995 Apr; 268(4 Pt 2):F588-94. PubMed ID: 7733315
[TBL] [Abstract][Full Text] [Related]
7. Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
Lassila M; Finckenberg P; Pere AK; Krogerus L; Ahonen J; Vapaatalo H; Nurminen ML
Br J Pharmacol; 2000 Jul; 130(6):1339-47. PubMed ID: 10903974
[TBL] [Abstract][Full Text] [Related]
8. [Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect of monotherapy (data from the trial SADKO-CHF)].
Skvortsov AA; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Mareev VIu; Belenkov IuN
Ter Arkh; 2005; 77(8):34-43. PubMed ID: 16206603
[TBL] [Abstract][Full Text] [Related]
9. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.
Brown NJ; Agirbasli M; Vaughan DE
Hypertension; 1999 Aug; 34(2):285-90. PubMed ID: 10454455
[TBL] [Abstract][Full Text] [Related]
10. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
Liu YH; Yang XP; Sharov VG; Nass O; Sabbah HN; Peterson E; Carretero OA
J Clin Invest; 1997 Apr; 99(8):1926-35. PubMed ID: 9109437
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of the angiotensin II receptor blocker EXP 3174 and of the angiotensin-converting enzyme inhibitor captopril on renal glomerular hemodynamics in the dog.
Heller J; Kramer HJ; Horácek V
Kidney Blood Press Res; 1997; 20(6):391-7. PubMed ID: 9453450
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide.
Li P; Chappell MC; Ferrario CM; Brosnihan KB
Hypertension; 1997 Jan; 29(1 Pt 2):394-400. PubMed ID: 9039133
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.
Wollert KC; Studer R; Doerfer K; Schieffer E; Holubarsch C; Just H; Drexler H
Circulation; 1997 Apr; 95(7):1910-7. PubMed ID: 9107180
[TBL] [Abstract][Full Text] [Related]
14. Kinins or nitric oxide, or both, are involved in the antitrophic effects of angiotensin converting enzyme inhibitors on diabetes-associated mesenteric vascular hypertrophy in the rat.
Rumble JR; Komers R; Cooper ME
J Hypertens; 1996 May; 14(5):601-7. PubMed ID: 8762203
[TBL] [Abstract][Full Text] [Related]
15. Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.
Allen TJ; Cao Z; Youssef S; Hulthen UL; Cooper ME
Diabetes; 1997 Oct; 46(10):1612-8. PubMed ID: 9313758
[TBL] [Abstract][Full Text] [Related]
16. Contribution of bradykinin B2 receptors to the inhibition by valsartan of systemic and renal effects of exogenous angiotensin II in salt-repleted humans.
Biggi A; Musiari L; Iori M; De Iaco G; Magnani G; Pelloni I; Pinelli S; Pelà GM; Novarini A; Cabassi A; Montanari A
J Pharmacol Exp Ther; 2010 Sep; 334(3):911-6. PubMed ID: 20504911
[TBL] [Abstract][Full Text] [Related]
17. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
[TBL] [Abstract][Full Text] [Related]
18. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
Vora JP; Oyama TT; Thompson MM; Anderson S
Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of aminopeptidase P potentiates wheal response to bradykinin in angiotensin-converting enzyme inhibitor-treated humans.
Kim KS; Kumar S; Simmons WH; Brown NJ
J Pharmacol Exp Ther; 2000 Jan; 292(1):295-8. PubMed ID: 10604961
[TBL] [Abstract][Full Text] [Related]
20. [Effects of long term therapy with angiotensin converting enzyme inhibitor quinapril, antagonist of receptors to angiotensin II valsartan, and combination of quinapril and valsartan in patients with moderate chronic heart failure. Main results of the SADKO-CHF study].
Skvortsov AA; Nasonova SN; Sychev AV; Orlova IaA; Baklanova NA; Masenko VP; Mareev VIu; Belenkov IuN
Kardiologiia; 2006; 46(7):33-51. PubMed ID: 16883264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
